Inventor · disambiguated record
Jerome F. Strauss
Also filed as: STRAUSS III JEROME · STRAUSS III JEROME F · STRAUSS III JEROME FRANK · STRAUSS JEROME
16 granted patents·4 pending applications·363 citations·filing 1994–2020
93Inventor score
Files withUNIV PENNSYLVANIA8UNIV VIRGINIA COMMONWEALTH6PENN STATE RES FOUND2GERTON GEORGE L1STRAUSS III JEROME F1
Top patents by PatentIndex Score
20 records- 0196US7306794B2Methods and compositions for the treatment of defects in lipoprotein metabolismUNIV PENNSYLVANIA·Filed 2005·Granted Dec 11, 2007·39 cites·15 claims
- 0294US5652224AMethods and compositions for gene therapy for the treatment of defects in lipoprotein metabolismUNIV PENNSYLVANIA·Filed 1995·Granted Jul 29, 1997·137 cites·13 claims
- 0393US6887463B2Methods and compositions for the treatment of defects in lipoprotein metabolismUNIV PENNSYLVANIA·Filed 2002·Granted May 3, 2005·38 cites·10 claims
- 0489US6174527B1Methods and compositions for gene therapy for the treatment of defects in lipoprotein metabolismUNIV PENNSYLVANIA·Filed 1996·Granted Jan 16, 2001·66 cites·4 claims
- 0584US7807366B2Genetic markers for assessing risk of premature birth resulting from preterm premature rupture of membranesUNIV VIRGINIA COMMONWEALTH·Filed 2007·Granted Oct 5, 2010·3 cites·4 claims
- 0671US5641636AMethod of predicting fetal membrane rupture based on matrix metalloproteinase-9 activityUNIV PENNSYLVANIA·Filed 1994·Granted Jun 24, 1997·29 cites·24 claims
- 0764US10723790B2Method for diagnosis of polycystic ovary syndrome (PCOS) by measuring levels of DENN/MADD domain containing 1A variant 2 (DENND1A variant 2)UNIV VIRGINIA COMMONWEALTH·Filed 2018·Granted Jul 28, 2020·0 cites·8 claims
- 0862US5698404AMethod of predicting fetal membrane rupture based on pro-matrix metalloproteinase-9 (pro-mmp-9)UNIV PENNSYLVANIA·Filed 1996·Granted Dec 16, 1997·24 cites·18 claims
- 0961US10865448B2Compositions and methods relating to DENND1A variant 2 and polycystic ovary syndromePENN STATE RES FOUND·Filed 2018·Granted Dec 15, 2020·0 cites·4 claims
- 1061US9676844B2Pharmaceutical compositions comprising DENND1A variant 2 and methods of use thereofUNIV VIRGINIA COMMONWEALTH·Filed 2014·Granted Jun 13, 2017·0 cites·23 claims
- 1157US10183991B2Antibodies that recognize a DENN/MADD-domain-containing 1A variant 2 (DENND1A variant 2)UNIV VIRGINIA COMMONWEALTH·Filed 2017·Granted Jan 22, 2019·0 cites·6 claims
- 1256US6140099AMethod of delaying fetal membrane rupture by inhibiting matrix metalloproteinase-9 activityUNIV PENNSYLVANIA·Filed 1997·Granted Oct 31, 2000·16 cites·8 claims
- 1354US9957567B2Methods relating to DENND1A Variant 2 and polycystic ovary syndromePENN STATE RES FOUND·Filed 2013·Granted May 1, 2018·0 cites·14 claims
- 1452US2011053159A1Genetic markers for assessing risk of premature birth resulting from preterm premature rupture membranesSTRAUSS III JEROME F·Filed 2010·Application pending·0 cites
- 1549US5807678AIdentification of gene mutations associated with congenital lipoid adrenal hyperplasiaUNIV CALIFORNIA·Filed 1995·Granted Sep 15, 1998·11 cites·9 claims
- 1649US2022243247A1Vaginal microbiome markers for prediction of prevention of preterm birth and other adverse pregnancy outcomesUNIV VIRGINIA COMMONWEALTH·Filed 2020·Application pending·0 cites
- 1748US8133687B2Labor biomarkers, methods comprising same, and methods targeting sameSTRAUSS JEROME F·Filed 2009·Granted Mar 13, 2012·0 cites·5 claims
- 1847US2022143067A1Methods for diagnosis and/or therapy of disorders that correlate with denndia variant 2UNIV VIRGINIA COMMONWEALTH·Filed 2020·Application pending·0 cites
- 1945US7662570B2Labor biomarkers, methods comprising same, and methods targeting sameUNIV PENNSYLVANIA·Filed 2006·Granted Feb 16, 2010·0 cites·6 claims
- 2036US2006228755A1Ectopic pregnancy markersGERTON GEORGE L·Filed 2005·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →